Drägerwerk stock trades at EUR 116.60, 7.0 percent below its 52-week high

Published on 10/09/2026 at 17:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Drägerwerk stock costs EUR 116.60 on October 9, 2026, versus EUR 111.60. Market value is EUR 2.2 billion; results due October 29, 2026.

Key points in brief

Drägerwerk stock traded at EUR 116.60 on October 9, 2026, up 4.48 percent versus the EUR 111.60 prior close.
The quote stood 7.0 percent below the EUR 125.40 52-week high and above the EUR 64.90 low.
Market capitalization was EUR 2.2 billion and the trailing P/E ratio was 12.60 on October 9, 2026.
MWB Research's reported target was EUR 130.00, 11.49 percent above the Lang & Schwarz price.
Third-quarter results are scheduled for October 29, 2026.

Pop-Art-Comic eines Rettungshelfers mit Gasmelder und Beatmungsmaske auf Halbton-Hintergrund — Drägerwerk AG & Co. KGaA Pop-Art Comic Rettungskraft Gasmelder Beatmungsmaske Sicherheitstechnik DE0005550636, Illustration mit AI erstellt.

Drägerwerk stock traded at EUR 116.60 at Lang & Schwarz on October 9, 2026 at 5:44 p.m. CEST, up 4.48 percent versus the prior close of EUR 111.60. The price was 7.0 percent below the 52-week high of EUR 125.40, giving the market report a clear range marker without turning the move into a forecast.

Quote closes below the high

The Lang & Schwarz bid was EUR 116.20 and the ask was EUR 117.00 at 5:44 p.m. CEST. The same-day quote range supplied for Drägerwerk was EUR 64.90 to EUR 125.40, while market capitalization stood at EUR 2.2 billion on October 9, 2026.

That placement matters because the share price remains materially above its 52-week low while sitting within 7.0 percent of the upper boundary. The comparison uses the same euro quotation basis for the price and range.

Valuation and next date

Drägerwerk carried a trailing P/E ratio of 12.60 and a trailing dividend yield of 0.02 percent on October 9, 2026. According to wallstreetONLINE on September 10, 2026, MWB Research had lifted its target for Drägerwerk to EUR 130.00. That target was 11.49 percent above the Lang & Schwarz price.

The company’s investor-relations page lists a 2026 outlook of 2.0 to 6.0 percent currency-adjusted revenue growth and an EBIT margin of 5.0 to 7.5 percent, linking the market valuation to a stated operating range. The next earnings date is October 29, 2026, according to Makkler.

Comparison with peers

Drägerwerk: plus 4.48 percent, P/E 12.60, market capitalization EUR 2.2 billion
Siemens Healthineers (Xetra, EUR): plus 2.33 percent, P/E 19.77, market capitalization EUR 43.8 billion
Getinge (Nasdaq Stockholm, SEK): plus 1.44 percent, P/E 25.76, market capitalization SEK 69.0 billion

Price after the Xetra close

Drägerwerk's euro quote stood at EUR 116.60 at Lang & Schwarz on October 9, 2026 at 5:44 p.m. CEST, after Xetra trading, compared with the EUR 111.60 Lang & Schwarz prior close from October 8, 2026. The further course of trading is shown by the continuously updated real-time quote of Drägerwerk stock.